NEW YORK and SALT LAKE CITY - Citeline announced an expanded partnership with Recursion (NASDAQ:RXRX) on Tuesday to integrate real-world data capabilities into the biotech company’s drug development ...

Recursion Pharmaceuticals Inc. stock reached a 52-week low, closing at $2.98. The biotechnology company, with a market capitalization of $1.58 billion, now trades 58% below its 52-week high of $7.18.

Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured in ...

Illinois head coach Shauna Green in a NCAA basketball game at the State Farm Center in Champaign on Tuesday, Feb. 17, 2026. Sports Copy Editor Illinois head coach Shauna Green in a NCAA basketball ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...

HOU win or tie OR IND loss or tie OR HOU clinches at least a tie in strength of victory tiebreaker over IND *Note: HOU needs the following to happen to clinch a tie in strength of victory with IND: ...

It was a special Saturday matinee at Ball Arena in Denver, to commemorate the 30th anniversary of the Quebec Nordiques’ move to the Rockies, the Colorado Avalanche was wearing its alternate jersey, ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...